To investigate the metabolic preference in breast cancer cell lines, we evaluated the expression of AMPK and HIF1α, which have been considered key modulators of oxidative and glycolytic metabolism, respectively [35,66,67,68]. The gene discussed is HIF1A; the disease is breast cancer.